Baron Health Care Fund Retail Shares

Under normal circumstances, the fund invests at least 80% of its net assets in equity securities in the form of common stock of companies engaged in the research, development, production, sale, delivery or distribution of products and services related to the health care industry. The Adviser uses various criteria to determine whether an issuer is engaged in activities related to the health care industry. It is non-diversified.

Baron Health Care Fund Retail Shares trades as BHCFX on NASDAQ. The company is classified in Financial Services / Asset Management and reports in USD.

The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Baron Health Care Fund Retail Shares can be compared against peers such as American Century One Choice 2065 Inv, Clifford Capital Partners Fund Investor Class, Clifford Capital Partners Fund Institutional Class, Western Asset Mortgage Opportunity Fund Inc., AMG Renaissance Large Cap Growth Fund - Class N, Neuberger Berman Mid Cap Instrinsic Value Fd Trust.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $109.42M, beta of 0.64, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

BHCFX currently shows total debt of N/A and beta of 0.64. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: 40-17G (2026-05-27 00:00:00), NPORT-P (2026-05-22 00:00:00), NPORT-P (2026-05-22 00:00:00), NPORT-P (2026-05-22 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.baroncapitalgroup.com/product-detail/baron-health-care-fund-bhcfx

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.